Apellis Pharmaceuticals: Audience

Apellis Pharmaceuticals is a global biopharmaceutical company that develops life-changing therapies targeting diseases driven by excessive activation of the complement cascade. The company focuses on pioneering targeted C3 therapies in areas such as hematology, ophthalmology, and nephrology.